Atlas maps plasma proteins to transform disease diagnosis and treatment

Researchers have developed the most comprehensive atlas linking plasma proteins to diseases and traits in over 53,000 individuals, offering groundbreaking insights for precision medicine. This resource uncovers 168,100 protein-disease associations and identifies new therapeutic targets.

Syncona to buy biotechnology company Freeline Therapeutics

Share this article Freeline leverages its AAV vector and capsid to deliver a functional copy of a therapeutic gene into human liver cells. Credit: crystal

November 23, 2023

Trump’s 2024 platform abandons calls to cut Medicare, broadly restrict abortion

WASHINGTON — Former President Trump says he “will not cut one penny” from Medicare and Social Security and steps back from calls for broad national

July 8, 2024

AI drug discovery company Genesis Therapeutics wins $200m in Series B round – Pharmaceutical Technology

The funds will go toward its Genesis Exploration of Molecular Space (GEMS) technology – a platform that uses generative and predictive AI technology to accelerate

August 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.